Raising the Bar in HR+/HER2- Early Breast Cancer: CDK4 and 6 Inhibitors

  Рет қаралды 2,069

PeerView Oncology

PeerView Oncology

2 жыл бұрын

Chair & Presenter, Joyce O’Shaughnessy, MD, Judy C. Boughey, MD, and Professor Stephen Johnston, discuss Breast Cancer in this CME/MOC/CC/NCPD/CPE activity titled “Raising the Bar in HR+/HER2- Early Breast Cancer: Multidisciplinary Strategies for Integrating the CDK4 and 6 Inhibitors.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/HYM865. CME/MOC/CC/NCPD/CPE credit will be available until December 15, 2022.

Пікірлер
Un coup venu de l’espace 😂😂😂
00:19
Nicocapone
Рет қаралды 7 МЛН
哈哈大家为了进去也是想尽办法!#火影忍者 #佐助 #家庭
00:33
火影忍者一家
Рет қаралды 102 МЛН
The Latest in Immunotherapy to Treat Cancer
53:53
UT Southwestern Medical Center
Рет қаралды 29 М.
Kamala Harris: The 2024 60 Minutes Interview
20:50
60 Minutes
Рет қаралды 708 М.
Update on Novel Therapies for Heart Failure (Milton Packer, MD)  February, 10, 2017
54:58
Houston Methodist DeBakey CV Education
Рет қаралды 11 М.
Immune Checkpoint Proteins
12:12
Creative BioMart
Рет қаралды 26 М.
Advancements in Care for Early-stage Breast Cancer 2024
1:25:09
Canadian Breast Cancer Network
Рет қаралды 242
Dr. Jason Fung: Fasting as a Therapeutic Option for Weight Loss
1:11:28